Merz Pharmaceuticals is an innovative pharmaceutical company specializing in the research and marketing of drugs for the treatment of neurological and psychiatric diseases. Merz is leading in the field of Alzheimer’s research and developed the world’s first drug for the treatment of moderate to severe stages of Alzheimer’s disease. In the neurological sector, Merz also offers drugs for the treatment of Parkinson’s and depression.
Another area of competence is dermatology. In this field, Merz products focus on the treatment of scars, acne, hair loss, and fungal diseases. In the area of metabolic disturbances, Merz offers therapies for liver disease and lipid metabolism disorders.
